Global Recombinant Erythropoietin Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Recombinant Erythropoietin Drugs Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 rhEPO
  • 1.2.2 Erythropoiesis-Stimulating Agents (ESA)
• 1.3 Market Analysis by Applications
  • 1.3.1 Chronic Kidney Disease
  • 1.3.2 Cancer Related Anemia
  • 1.3.3 Others
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2014-2024)
    • 1.4.1.2 Canada Market States and Outlook (2014-2024)
    • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2014-2024)
    • 1.4.2.2 France Market States and Outlook (2014-2024)
    • 1.4.2.3 UK Market States and Outlook (2014-2024)
    • 1.4.2.4 Russia Market States and Outlook (2014-2024)
    • 1.4.2.5 Italy Market States and Outlook (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2014-2024)
    • 1.4.3.2 Japan Market States and Outlook (2014-2024)
    • 1.4.3.3 Korea Market States and Outlook (2014-2024)
    • 1.4.3.4 India Market States and Outlook (2014-2024)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
    • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
    • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
    • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Amgen
  • 2.1.1 Business Overview
  • 2.1.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Amgen Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 F. Hoffmann-La Roche Ltd
  • 2.2.1 Business Overview
  • 2.2.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Roche
  • 2.3.1 Business Overview
  • 2.3.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Roche Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Johnson & Johnson
  • 2.4.1 Business Overview
  • 2.4.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Johnson & Johnson Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Teva Pharmaceutical Industries Ltd
  • 2.5.1 Business Overview
  • 2.5.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Kyowa Hakko Kirin
  • 2.6.1 Business Overview
  • 2.6.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Biocon Limited
  • 2.7.1 Business Overview
  • 2.7.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Biocon Limited Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Celltrion, Inc
  • 2.8.1 Business Overview
  • 2.8.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Celltrion, Inc Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 3SBio Group
  • 2.9.1 Business Overview
  • 2.9.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 3SBio Group Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 LG Life Sciences Ltd
  • 2.10.1 Business Overview
  • 2.10.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Intas Pharmaceuticals Ltd
  • 2.11.1 Business Overview
  • 2.11.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Sun Pharmaceutical Industries Ltd
  • 2.12.1 Business Overview
  • 2.12.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Dr. Reddy's Laboratories Ltd
  • 2.13.1 Business Overview
  • 2.13.2 Recombinant Erythropoietin Drugs Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Recombinant Erythropoietin Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

• 3.1 Global Recombinant Erythropoietin Drugs Sales and Market Share by Manufacturer (2017-2018)
• 3.2 Global Recombinant Erythropoietin Drugs Revenue and Market Share by Manufacturer (2017-2018)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Recombinant Erythropoietin Drugs Manufacturer Market Share in 2018
  • 3.3.2 Top 6 Recombinant Erythropoietin Drugs Manufacturer Market Share in 2018
• 3.4 Market Competition Trend

4 Global Recombinant Erythropoietin Drugs Market Analysis by Regions

• 4.1 Global Recombinant Erythropoietin Drugs Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Recombinant Erythropoietin Drugs Sales and Market Share by Regions (2014-2019)
  • 4.1.2 Global Recombinant Erythropoietin Drugs Revenue and Market Share by Regions (2014-2019)
• 4.2 North America Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 4.3 Europe Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 4.5 South America Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)

5 North America Recombinant Erythropoietin Drugs by Country

• 5.1 North America Recombinant Erythropoietin Drugs Sales, Revenue and Market Share by Country
  • 5.1.1 North America Recombinant Erythropoietin Drugs Sales and Market Share by Country (2014-2019)
  • 5.1.2 North America Recombinant Erythropoietin Drugs Revenue and Market Share by Country (2014-2019)
• 5.2 United States Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 5.3 Canada Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 5.4 Mexico Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)

6 Europe Recombinant Erythropoietin Drugs by Country

• 6.1 Europe Recombinant Erythropoietin Drugs Sales, Revenue and Market Share by Country
  • 6.1.1 Europe Recombinant Erythropoietin Drugs Sales and Market Share by Country (2014-2019)
  • 6.1.2 Europe Recombinant Erythropoietin Drugs Revenue and Market Share by Country (2014-2019)
• 6.2 Germany Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 6.3 UK Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 6.4 France Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 6.5 Russia Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 6.6 Italy Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)

7 Asia-Pacific Recombinant Erythropoietin Drugs by Country

• 7.1 Asia-Pacific Recombinant Erythropoietin Drugs Sales, Revenue and Market Share by Country
  • 7.1.1 Asia-Pacific Recombinant Erythropoietin Drugs Sales and Market Share by Country (2014-2019)
  • 7.1.2 Asia-Pacific Recombinant Erythropoietin Drugs Revenue and Market Share by Country (2014-2019)
• 7.2 China Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 7.3 Japan Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 7.4 Korea Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 7.5 India Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 7.6 Southeast Asia Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)

8 South America Recombinant Erythropoietin Drugs by Country

• 8.1 South America Recombinant Erythropoietin Drugs Sales, Revenue and Market Share by Country
  • 8.1.1 South America Recombinant Erythropoietin Drugs Sales and Market Share by Country (2014-2019)
  • 8.1.2 South America Recombinant Erythropoietin Drugs Revenue and Market Share by Country (2014-2019)
• 8.2 Brazil Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 8.3 Argentina Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 8.4 Colombia Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)

9 Middle East and Africa Recombinant Erythropoietin Drugs by Countries

• 9.1 Middle East and Africa Recombinant Erythropoietin Drugs Sales, Revenue and Market Share by Country
  • 9.1.1 Middle East and Africa Recombinant Erythropoietin Drugs Sales and Market Share by Country (2014-2019)
  • 9.1.2 Middle East and Africa Recombinant Erythropoietin Drugs Revenue and Market Share by Country (2014-2019)
• 9.2 Saudi Arabia Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 9.3 Turkey Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 9.4 Egypt Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 9.5 Nigeria Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)
• 9.6 South Africa Recombinant Erythropoietin Drugs Sales and Growth Rate (2014-2019)

10 Global Recombinant Erythropoietin Drugs Market Segment by Type

• 10.1 Global Recombinant Erythropoietin Drugs Sales, Revenue and Market Share by Type (2014-2019)
  • 10.1.1 Global Recombinant Erythropoietin Drugs Sales and Market Share by Type (2014-2019)
  • 10.1.2 Global Recombinant Erythropoietin Drugs Revenue and Market Share by Type (2014-2019)
• 10.2 rhEPO Sales Growth and Price
  • 10.2.1 Global rhEPO Sales Growth (2014-2019)
  • 10.2.2 Global rhEPO Price (2014-2019)
• 10.3 Erythropoiesis-Stimulating Agents (ESA) Sales Growth and Price
  • 10.3.1 Global Erythropoiesis-Stimulating Agents (ESA) Sales Growth (2014-2019)
  • 10.3.2 Global Erythropoiesis-Stimulating Agents (ESA) Price (2014-2019)

11 Global Recombinant Erythropoietin Drugs Market Segment by Application

• 11.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Application (2014-2019)
• 11.2 Chronic Kidney Disease Sales Growth (2014-2019)
• 11.3 Cancer Related Anemia Sales Growth (2014-2019)
• 11.4 Others Sales Growth (2014-2019)

12 Recombinant Erythropoietin Drugs Market Forecast (2019-2024)

• 12.1 Global Recombinant Erythropoietin Drugs Sales, Revenue and Growth Rate (2019-2024)
• 12.2 Recombinant Erythropoietin Drugs Market Forecast by Regions (2019-2024)
  • 12.2.1 North America Recombinant Erythropoietin Drugs Market Forecast (2019-2024)
  • 12.2.2 Europe Recombinant Erythropoietin Drugs Market Forecast (2019-2024)
  • 12.2.3 Asia-Pacific Recombinant Erythropoietin Drugs Market Forecast (2019-2024)
  • 12.2.4 South America Recombinant Erythropoietin Drugs Market Forecast (2019-2024)
  • 12.2.5 Middle East and Africa Recombinant Erythropoietin Drugs Market Forecast (2019-2024)
• 12.3 Recombinant Erythropoietin Drugs Market Forecast by Type (2019-2024)
  • 12.3.1 Global Recombinant Erythropoietin Drugs Sales Forecast by Type (2019-2024)
  • 12.3.2 Global Recombinant Erythropoietin Drugs Market Share Forecast by Type (2019-2024)
• 12.4 Recombinant Erythropoietin Drugs Market Forecast by Application (2019-2024)
  • 12.4.1 Global Recombinant Erythropoietin Drugs Sales Forecast by Application (2019-2024)
  • 12.4.2 Global Recombinant Erythropoietin Drugs Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology